Journal of Innovative Optical Health Sciences, Volume. 17, Issue 1, 2350020(2024)

Anti-PD1 antibody and not anti-LAG-3 antibody improves the antitumor effect of photodynamic therapy for treating metastatic breast cancer

Shan Long1,2, Yibing Zhao3, Yuanyuan Xu2, Bo Wang4, Haixia Qiu2, Hongyou Zhao5, Jing Zeng2, Defu Chen5, Hui Li2,6, Jiakang Shao2,6, Xiaosong Li3、*, and Ying Gu1,2、**
Author Affiliations
  • 1School of Medicine, Nankai University, Tianjin, 300072, P. R. China
  • 2Department of Laser Medicine. The First Medical Center of Chinese PLA General Hospital, Beijing 100853, P. R. China
  • 3Department of Oncology, The Seventh Medical Center of Chinese PLA General Hospital, Beijing 100039, P. R. China
  • 4School of Basic Medicine, Guizhou Medical University, Guiyang 550025, Guizhou, P. R. China
  • 5College of Medical Technology, Beijing Institute of Technology, Beijing 100081, P. R. China
  • 6Medical School of Chinese PLA, Beijing 100853, P. R. China
  • show less
    Figures & Tables(0)
    Tools

    Get Citation

    Copy Citation Text

    Shan Long, Yibing Zhao, Yuanyuan Xu, Bo Wang, Haixia Qiu, Hongyou Zhao, Jing Zeng, Defu Chen, Hui Li, Jiakang Shao, Xiaosong Li, Ying Gu. Anti-PD1 antibody and not anti-LAG-3 antibody improves the antitumor effect of photodynamic therapy for treating metastatic breast cancer[J]. Journal of Innovative Optical Health Sciences, 2024, 17(1): 2350020

    Download Citation

    EndNote(RIS)BibTexPlain Text
    Save article for my favorites
    Paper Information

    Category: Research Articles

    Received: Feb. 2, 2023

    Accepted: May. 14, 2023

    Published Online: Feb. 28, 2024

    The Author Email: Li Xiaosong (lixiaosong@hotmail.com), Gu Ying (guyinglaser301@163.com)

    DOI:10.1142/S1793545823500207

    Topics